اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدIdentify treatment effect patterns for personalised decisions
469
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
In personalised decision making, evidence is required to determine suitable actions for individuals. Such evidence can be obtained by identifying treatment effect heterogeneity in different subgroups of the population. In this paper, we design a new type of pattern, treatment effect pattern to represent and discover treatment effect heterogeneity from data for determining whether a treatment will work for an individual or not. Our purpose is to use the computational power to find the most specific and relevant conditions for individuals with respect to a treatment or an action to assist with personalised decision making. Most existing work on identifying treatment effect heterogeneity takes a top-down or partitioning based approach to search for subgroups with heterogeneous treatment effects. We propose a bottom-up generalisation algorithm to obtain the most specific patterns that fit individual circumstances the best for personalised decision making. For the generalisation, we follow a consistency driven strategy to maintain inner-group homogeneity and inter-group heterogeneity of treatment effects. We also employ graphical causal modelling technique to identify adjustment variables for reliable treatment effect pattern discovery. Our method can find the treatment effect patterns reliably as validated by the experiments. The method is faster than the two existing machine learning methods for heterogeneous treatment effect identification and it produces subgroups with higher inner-group treatment effect homogeneity.
قيم البحث
اقرأ أيضاً
Data-driven individualized decision making has recently received increasing research interests. Most existing methods rely on the assumption of no unmeasured confounding, which unfortunately cannot be ensured in practice especially in observational s
tudies. Motivated by the recent proposed proximal causal inference, we develop several proximal learning approaches to estimating optimal individualized treatment regimes (ITRs) in the presence of unmeasured confounding. In particular, we establish several identification results for different classes of ITRs, exhibiting the trade-off between the risk of making untestable assumptions and the value function improvement in decision making. Based on these results, we propose several classification-based approaches to finding a variety of restricted in-class optimal ITRs and develop their theoretical properties. The appealing numerical performance of our proposed methods is demonstrated via an extensive simulation study and one real data application.
Accurate models of clinical actions and their impacts on disease progression are critical for estimating personalized optimal dynamic treatment regimes (DTRs) in medical/health research, especially in managing chronic conditions. Traditional statisti
cal methods for DTRs usually focus on estimating the optimal treatment or dosage at each given medical intervention, but overlook the important question of when this intervention should happen. We fill this gap by developing a two-step Bayesian approach to optimize clinical decisions with timing. In the first step, we build a generative model for a sequence of medical interventions-which are discrete events in continuous time-with a marked temporal point process (MTPP) where the mark is the assigned treatment or dosage. Then this clinical action model is embedded into a Bayesian joint framework where the other components model clinical observations including longitudinal medical measurements and time-to-event data conditional on treatment histories. In the second step, we propose a policy gradient method to learn the personalized optimal clinical decision that maximizes the patient survival by interacting the MTPP with the model on clinical observations while accounting for uncertainties in clinical observations learned from the posterior inference of the Bayesian joint model in the first step. A signature application of the proposed approach is to schedule follow-up visitations and assign a dosage at each visitation for patients after kidney transplantation. We evaluate our approach with comparison to alternative methods on both simulated and real-world datasets. In our experiments, the personalized decisions made by the proposed method are clinically useful: they are interpretable and successfully help improve patient survival.
In this study, we develop a novel estimation method of the quantile treatment effects (QTE) under the rank invariance and rank stationarity assumptions. Ishihara (2020) explores identification of the nonseparable panel data model under these assumpti
ons and propose a parametric estimation based on the minimum distance method. However, the minimum distance estimation using this process is computationally demanding when the dimensionality of covariates is large. To overcome this problem, we propose a two-step estimation method based on the quantile regression and minimum distance method. We then show consistency and asymptotic normality of our estimator. Monte Carlo studies indicate that our estimator performs well in finite samples. Last, we present two empirical illustrations, to estimate the distributional effects of insurance provision on household production and of TV watching on child cognitive development.
Forest-based methods have recently gained in popularity for non-parametric treatment effect estimation. Building on this line of work, we introduce causal survival forests, which can be used to estimate heterogeneous treatment effects in a survival a
nd observational setting where outcomes may be right-censored. Our approach relies on orthogonal estimating equations to robustly adjust for both censoring and selection effects. In our experiments, we find our approach to perform well relative to a number of baselines.
Recent development in data-driven decision science has seen great advances in individualized decision making. Given data with individual covariates, treatment assignments and outcomes, researchers can search for the optimal individualized treatment r
ule (ITR) that maximizes the expected outcome. Existing methods typically require initial estimation of some nuisance models. The double robustness property that can protect from misspecification of either the treatment-free effect or the propensity score has been widely advocated. However, when model misspecification exists, a doubly robust estimate can be consistent but may suffer from downgraded efficiency. Other than potential misspecified nuisance models, most existing methods do not account for the potential problem when the variance of outcome is heterogeneous among covariates and treatment. We observe that such heteroscedasticity can greatly affect the estimation efficiency of the optimal ITR. In this paper, we demonstrate that the consequences of misspecified treatment-free effect and heteroscedasticity can be unified as a covariate-treatment dependent variance of residuals. To improve efficiency of the estimated ITR, we propose an Efficient Learning (E-Learning) framework for finding an optimal ITR in the multi-armed treatment setting. We show that the proposed E-Learning is optimal among a regular class of semiparametric estimates that can allow treatment-free effect misspecification. In our simulation study, E-Learning demonstrates its effectiveness if one of or both misspecified treatment-free effect and heteroscedasticity exist. Our analysis of a Type 2 Diabetes Mellitus (T2DM) observational study also suggests the improved efficiency of E-Learning.
الأسئلة المقترحة
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
